RECORDATI
ActiveSummary
RECORDATI has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.0m and a net result of €1.7m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 6,139 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 2
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Lodewijk Bastiaan Sibeijn |
|
| Juan Vila Alvarez |
|
| EY Réviseurs d'entreprises |
|
| Luigi Longinotti |
|
| Andrea Rizzi |
|
| Benoît Slavicek |
|
| PESCATORE Scott Lyons |
|
Owners and capital
Owners
3 ownersChain of control
- Recordati Industrial Chimica E Farmaceutica S.p.A.IT
- Recordati Rare Diseases SARLFR
- RECORDATI
Highest known parent: Recordati Industrial Chimica E Farmaceutica S.p.A. (Italy). The sources do not say who stands above it.
Owners 3
- Recordati Rare Diseases SARLFRparentSourceown accounts 2025100%
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. IN BREVE RECORDATI S.P.A.ITparentSourceLEI registerconsolidated
- Recordati Industrial Chimica E Farmaceutica S.p.A.ITconsolidating parentconsolidates
According to the 2025 annual accounts of RECORDATI and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 26-01-2024 Converted to unavailable equity